Dhg Pharmaceutical Joint-Stock Co operates in the Medicinals and botanicals sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Dhg Pharmaceutical Joint-Stock Co with three other
companies in this sector in VIETNAM :
Traphaco JSC
(2019
sales of 1.71 trillion Vietnamese Dong [US$73.72 million]
),
DOMESCO Medical Import Export Joint Stock Corp
(1.47 trillion Vietnamese Dong [US$63.29 million]
), and
Hatay Pharmaceutical JSC
(2.04 trillion Vietnamese Dong [US$88.02 million]
).
Sales Analysis.
Dhg Pharmaceutical Joint-Stock Co reported sales of 3.90 trillion Vietnamese Dong (US$167.95 million)
for the
year ending
December of 2019.
This
represents
a very small
increase of 0.4%
versus 2018, when the company's sales were 3.88 trillion Vietnamese Dong .
Despite this increase, sales are still
below the level achieved in 2017, when Dhg Pharmaceutical Joint-Stock Co
reported sales of 4.06 trillion Vietnamese Dong .
The sales level in 2019 was fairly close to the level five years ago: in 2014, Dhg Pharmaceutical Joint-Stock Co had sales
of 3.91 trillion Vietnamese Dong .
Sales of Supplements saw an increase
that was more than double the company's growth rate: sales were up
11.8% in 2019, from
377.75 billion Vietnamese Dong to 422.47 billion Vietnamese Dong .
Dhg Pharmaceutical Joint-Stock Co also saw significant increases in sales in
Other Activities (up 5.1% to 200.82 billion Vietnamese Dong )
.
Not all segments of Dhg Pharmaceutical Joint-Stock Co experienced an increase in sales in 2019:
sales of Medicine fell 1.2% to 3.27 trillion Vietnamese Dong .